10.6084/m9.figshare.c.3711511_D5.v1
Amy Cranston
Amy
Cranston
Deborah Stocken
Deborah
Stocken
Elaine Stamp
Elaine
Stamp
David Roblin
David
Roblin
Julia Hamlin
Julia
Hamlin
James Langtry
James
Langtry
Ruth Plummer
Ruth
Plummer
Alan Ashworth
Alan
Ashworth
John Burn
John
Burn
Neil Rajan
Neil
Rajan
Additional file 5: of Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial
Springer Nature
2017
CYLD defective tumours
Tropomyosin receptor kinase (TRK) inhibitor
Cylindromatosis
TRK inhibition
Pegcantratinib
CYLD
2017-03-07 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_5_of_Tropomyosin_Receptor_Antagonism_in_Cylindromatosis_TRAC_an_early_phase_trial_of_a_topical_tropomyosin_kinase_inhibitor_as_a_treatment_for_inherited_CYLD_defective_skin_tumours_study_protocol_for_a_randomised_controlled_trial/4732276
SPIRIT figure showing schedule of events in cohort 1 of the trial. (PDF 140 kb)